| 1 |
35614973 | Structure-Activity Relationships of Dopamine Transporter Pharmacological Chaperones. | 2022 |
1 |
| 2 |
33692710 | Case Report: Bupropion Reduces the [123I]FP-CIT Binding to Striatal Dopamine Transporter. | 2021 |
1 |
| 3 |
31009648 | Differential effects of psychoactive substances on human wildtype and polymorphic T356M dopamine transporters (DAT). | 2019 Jun 15 |
2 |
| 4 |
31361666 | Bupropion Causes Misdiagnosis in Brain Dopamine Transporter Imaging for Parkinsonism. | 2019 Sep/Oct |
5 |
| 5 |
30026780 | Δ3,2-Hydroxybakuchiol Attenuates Depression in Multiple Rodent Models Possibly by Inhibition of Monoamine Transporters in Brain. | 2018 |
2 |
| 6 |
28220701 | Deconstructed Analogues of Bupropion Reveal Structural Requirements for Transporter Inhibition versus Substrate-Induced Neurotransmitter Release. | 2017 Jun 21 |
1 |
| 7 |
29089770 | Bupropion interferes with the image diagnosis of Parkinson's disease. | 2017 |
4 |
| 8 |
27555326 | Pharmacological Chaperones of the Dopamine Transporter Rescue Dopamine Transporter Deficiency Syndrome Mutations in Heterologous Cells. | 2016 Oct 14 |
7 |
| 9 |
24878537 | Part Two: Evaluation of N-methylbupropion as a Potential Bupropion Prodrug. | 2014 May 28 |
1 |
| 10 |
22947179 | Analysis of 34 candidate genes in bupropion and placebo remission. | 2013 May |
2 |
| 11 |
23036826 | The interaction between dopamine transporter function, gender differences, and possible laterality in depression. | 2013 Jan 30 |
3 |
| 12 |
22119468 | (±)-2-(N-tert-Butylamino)-3'-[(125)I]-iodo-4'-azidopropiophenone: a dopamine transporter and nicotinic acetylcholine receptor photoaffinity ligand based on bupropion (Wellbutrin, Zyban). | 2012 Jan 1 |
5 |
| 13 |
19969097 | Acute effect of the anti-addiction drug bupropion on extracellular dopamine concentrations in the human striatum: an [11C]raclopride PET study. | 2010 Mar |
2 |
| 14 |
19897080 | Pharmacological and neurotoxicological actions mediated by bupropion and diethylpropion. | 2009 |
2 |
| 15 |
18930778 | Striatal lesions in delusional parasitosis revealed by magnetic resonance imaging. | 2008 Dec 12 |
2 |
| 16 |
17264803 | Dopamine transporter polymorphisms are associated with short-term response to smoking cessation treatment. | 2007 Jan |
2 |
| 17 |
17500623 | Joint effect of dopaminergic genes on likelihood of smoking following treatment with bupropion SR. | 2007 May |
1 |
| 18 |
16923164 | Gain of function mutants reveal sites important for the interaction of the atypical inhibitors benztropine and bupropion with monoamine transporters. | 2006 Sep |
3 |
| 19 |
16213028 | Dopamine transporter availability in medication free and in bupropion treated depression: a 99mTc-TRODAT-1 SPECT study. | 2005 Dec |
6 |
| 20 |
15787205 | [Change of dopamine transporter activity (DAT) during the action of bupropion (in depression)]. | 2004 Jun |
5 |
| 21 |
14550679 | In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography. | 2003 Oct 15 |
10 |
| 22 |
12112414 | Dopamine transporter-dependent induction of C-Fos in HEK cells. | 2002 Jul |
1 |
| 23 |
12185406 | Bupropion occupancy of the dopamine transporter is low during clinical treatment. | 2002 Aug |
10 |
| 24 |
10773037 | Toward development of an in vitro model of methamphetamine-induced dopamine nerve terminal toxicity. | 2000 May |
1 |
| 25 |
7717410 | Association of attention-deficit disorder and the dopamine transporter gene. | 1995 Apr |
2 |